These results suggest that PDIA3 may be associated with enhanced anti-tumor immune response in OSCC, because Th2, NK, Tgd, and Th1 generally promote the anti-tumor immune responses [[34], [35], [36]]. This evidence concerns the gene PDIA3 and neoplasm.